Callan Family Office’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.57M | Buy |
56,136
+23,772
| +73% | +$3.63M | 0.27% | 76 |
|
|
2025
Q1 | $5.37M | Sell |
32,364
-3,750
| -10% | -$622K | 0.4% | 55 |
|
|
2024
Q4 | $5.22M | Buy |
36,114
+26,331
| +269% | +$3.81M | 0.33% | 53 |
|
|
2024
Q3 | $1.59M | Buy |
9,783
+2,711
| +38% | +$439K | 0.27% | 46 |
|
|
2024
Q2 | $1.03M | Buy |
7,072
+1,640
| +30% | +$240K | 0.2% | 58 |
|
|
2024
Q1 | $859K | Sell |
5,432
-68
| -1% | -$10.8K | 0.2% | 46 |
|
|
2023
Q4 | $862K | Buy |
5,500
+270
| +5% | +$42.3K | 0.21% | 45 |
|
|
2023
Q3 | $815K | Sell |
5,230
-430
| -8% | -$67K | 0.22% | 46 |
|
|
2023
Q2 | $937K | Sell |
5,660
-249
| -4% | -$41.2K | 0.25% | 47 |
|
|
2023
Q1 | $916K | Buy |
5,909
+1,495
| +34% | +$232K | 0.22% | 65 |
|
|
2022
Q4 | $780K | Buy |
+4,414
| New | +$780K | 0.25% | 41 |
|